Image Credit: Health and me
The relationship between memory and eating behavior has been of considerable interest to scientists in recent years. While it is common for food intake to be associated with hunger or emotional states, innovative research by the Monell Chemical Senses Center has found that another critical component influences our eating habits—memory. The studies revealed that the food-related memory system of the brain could be a direct contributor to how much and what we eat. This may prove important in the context of overeating, food cravings, and obesity.
An underemphasized player in eating behavior studies is memory. But researchers from Washington University School of Medicine in St. Louis, led by Dr. Guillaume de Lartigue, published in Nature Metabolism, revealed an entirely new phenomenon: there are certain neurons in the brain that store food memories, specifically those that have a lot of sugar and fat. Such neurons in the hippocampus directly impact food intake and weight gain and establish a surprising relationship between memory and metabolism.
These neurons encode the spatial location of nutrient-rich foods, thus essentially forming a "memory trace" for sugar and fat. These memories act as a strong motivator for eating behavior and drive individuals to seek out such food sources again, even in environments where food is readily available.
Dr. de Lartigue's group found that blocking these neurons reduced the capacity of an animal to remember sugar-related experiences. In simpler words, if these neurons were blocked, the animals ate less sugar, and they gained much less weight even though they were fed a diet loaded with sugar and fat. Conversely, activating these neurons enhanced the memory for food in the animals and increased consumption.
This finding is impportant because it suggests that food memories should not be considered as passive recollections of pleasurable experiences but rather as active triggers of food intake and behavior. It opens possibilities to use these insights in better management of overeating and prevention of diet-induced obesity.
What is important about this discovery is its implications for relieving the growing obesity epidemic. Obesity has long been associated with overeating and specifically, the consumption of calorie-dense, nutrient-poor foods which are high in fat and sugar. The study of Monell reported that brain circuits controlling memory could be an important component that drives the behavior.
In the present world, food is constantly advertised, and there are environmental cues everywhere. As such, food memories have emerged as a vital part of eating habits. As Dr. de Lartigue points out, these circuits of memory may cause overeating due to the plentiful food cues associated with pleasure. In essence, these memories may cause a craving to result in the consumption of sugary or fatty foods when one may not feel hungry.
Another interesting aspect of this study is the specificity of memory circuits it detects. The scientists were able to determine that the neurons that are responsible for encoding sugar-related memories only influence sugar intake, while the neurons responsible for fat-related memories affect fat consumption. This specificity shows that the brain has finely tuned circuits designed to differentiate between various types of food and drive behavior accordingly.
Separation of sugar and fat memory circuits might have occurred as a function because in the wild, most foodstuffs hardly combine sugar and fats, thus facilitating survival when remembering and acting appropriately on nutrient-dense food sources. This capability of storing food-specific memories might account for why most people experience a craving for either sweet or fatty food in the presence of environmental cues related to these nutrients.
The research holds great promise for the development of new treatments for obesity. By targeting the memory circuits in the hippocampus, it may be possible to disrupt the food-related memories that drive unhealthy eating behavior. This may provide a new approach to managing overeating and weight gain, especially in a society where food is omnipresent and easily accessible.
Dr. de Lartigue and his colleagues propose that these neurons are necessary for associating sensory stimuli, such as taste and smell, with the consumption of food. Blocking the memory mechanisms that drive the desire for calorie-rich foods may represent a powerful intervention to treat obesity and enhance metabolic health.
The brain's reward system is also closely linked to food memories. Scientists have discovered that high-glycemic foods cause a rapid increase in blood sugar levels, stimulating pleasure and reward areas of the brain. Such foods give a sense of satisfaction, and it reinforces the need to eat them again. In the long term, the brain becomes conditioned to seek out such foods, creating a vicious cycle of overeating.
Overeating can also be linked to memory modification in the brain's reward system, which eventually creates a reduced response to cues related to food. The same thing happens in addiction, where higher amounts of the substance are required for the same amount of reward. The vicious cycle of eating, facilitated by brain activation and food memories, might explain why people easily gain weight yet have difficulty keeping it off.
Findings at the Monell Chemical Senses Center have increased our knowledge on the intricate connection between memory and eating behavior. The specific role that food-related memories play in food intake and weight gain has been identified through this study, providing useful information regarding how memory circuits in the brain might influence eating behavior. This research could open the doors to innovative treatments against overeating and obesity, helping people make healthier food choices and improve their metabolic health.
Separate orexigenic hippocampal ensembles shape dietary choice by enhancing contextual memory and motivation. Nat Metab. 2025
Effects of dietary glycemic index on brain regions related to reward and craving in men. Am J Clin Nutr. 2013
Credits: Canva
For people living with primary sclerosing cholangitis or PSC, medical options have always been painfully limited. Until now, there has been no approved drug that can slow the disease itself. Treatment has mostly meant managing symptoms and waiting, often for years, until a liver transplant becomes the only option. That is why new results around a monoclonal antibody called nebokitug are being seen as a turning point.
Researchers from the University of California Davis have reported promising findings from a Phase 2 clinical trial showing that nebokitug appears safe and may actually reduce liver inflammation and scarring. The study was published in the American Journal of Gastroenterology and has brought cautious optimism to both doctors and patients.
PSC is a rare, long-term liver disease that mainly affects the bile ducts. These ducts act like tiny pipelines that carry bile from the liver to the small intestine, where it helps digest fats. In PSC, these ducts become inflamed, damaged, and scarred over time. As they narrow, bile starts backing up in the liver, slowly causing liver injury.
Many people with PSC also have inflammatory bowel disease, especially ulcerative colitis. This strong link has led researchers to believe that ongoing gut inflammation may trigger immune reactions that damage the liver as well. Symptoms can range from extreme tiredness and itching to yellowing of the skin and eyes. Some patients have no symptoms at all in the early stages, which makes the disease harder to catch.
One of the biggest challenges with PSC is that doctors have not had a way to stop the scarring process itself. Once fibrosis sets in, it slowly progresses and increases the risk of liver failure and bile duct cancer. While medications can help with itching or infections, they do not change the course of the disease. This gap in treatment is what makes the nebokitug study so important.
Nebokitug is a lab-made antibody designed to block a protein called CCL24. This protein plays a key role in driving inflammation and fibrosis in the liver. In people with PSC, CCL24 levels are higher than normal and are found around the bile ducts where damage is most severe.
By blocking CCL24, nebokitug aims to calm the immune response and slow down the scarring process. Earlier lab and animal studies suggested this approach could work. The new trial is one of the first to test this idea in people with PSC.
The Phase 2 study included 76 patients from five countries. Participants received either one of two doses of nebokitug or a placebo through an IV every three weeks for 15 weeks. The main goal was to check safety, since this was still an early-stage trial.
The results were encouraging. Nebokitug was found to be safe and well tolerated. More importantly, patients who already had more advanced liver scarring showed improvements in liver stiffness and markers linked to fibrosis when compared to those on placebo. These changes suggest that the drug may be doing more than just easing symptoms.
Experts involved in the study say these findings could change the future of PSC care. Reducing inflammation and fibrosis could slow disease progression and delay or even prevent the need for a transplant in some patients. While larger trials are still needed, nebokitug represents one of the strongest signals yet that PSC may finally have a disease-modifying treatment on the horizon.
Credits: Canva
Now, drinking beer too could increase the risk of mouth cancer. On Tuesday, researchers at the Tata Memorial Centre (TMC) reported this adding new evidence. They found a 59 per cent higher risk of mouth cancer in people who drank, on average, just two grams of alcohol from beer daily, compared with those who did not drink. The research suggests that there may not be any safe limit to drink.
Their study in India's large scale analysis that probs link between alcohol and cancer of the buccal mucosa. This is the pink lining of cheeks and lips. In India, this kind of cancer is the second most common malignancy in India after breast cancer. It also leads to 1,40,000 new cases and nearly 80,000 deaths each year.
People who consume more than one glass of alcohol a day and chew tobacco on a day to day basis are five times more at risk of developing this cancer as compared to those who do not drink or chew tobacco.
The findings of the study was published in the journal BMJ Global Health and it suggests that joint use of both, alcohol and tobacco leads to 62 per cent of all buccal mucosa cancer in the country.
As Telegraph reported, Tata Memorial Centre for Cancer Epidemiology unit's head of molecular epidemiology and population genomics unit Sharayu Mhatre said, "We see an unmistakable pattern: the more alcohol people drink, the greater their risk of buccal mucosal cancer."
Buccal mucosal cancer continues to pose a serious public health challenge in India. Among 100 patients diagnosed with locally advanced stages of the disease, 57 die within five years, a mortality rate that experts say highlights the urgent need for prevention, early detection, and stronger regulation of risk factors.
While the link between alcohol and cancer is well known, new findings reinforce just how dangerous alcohol consumption can be for oral health. Researchers found that people who consumed alcohol had a 68% higher risk of developing buccal mucosal cancer compared to non-drinkers.
What stood out most was the type of alcohol consumed. Unregulated, locally brewed liquor carried the highest risk, increasing cancer likelihood by 87%, compared to 72% among consumers of regulated, commercially sold drinks. Experts point out that these local brews often contain significantly higher ethanol concentrations and lack quality control.
The study analyzed drinking patterns among over 3,700 participants, comparing cancer patients with healthy individuals. Alcohol types ranged from beer and spirits like whisky and vodka to traditional local drinks such as bangla and tharra. Ethanol levels varied widely—from 5% in beer to as high as 90% in some locally distilled spirits.
Alarmingly, increased cancer risk was seen even at low levels of alcohol intake. As little as two grams of alcohol a day from beer, or roughly one glass of stronger liquor, was enough to raise concern.
The risk escalates dramatically when alcohol use is combined with tobacco chewing. Tobacco alone raised cancer risk by 200%, alcohol alone by 76%, but together, the risk shot up to 346%. Researchers explain that alcohol may damage the mouth’s protective lining, making it easier for tobacco-related carcinogens to penetrate and cause harm.
Health experts stress that these findings underline the need for greater public awareness, stricter monitoring of locally brewed alcohol, and stronger prevention strategies. The World Health Organization has already warned that no level of alcohol is safe, noting that even light or moderate drinking contributes to a significant number of alcohol-related cancers globally.
For India, where oral cancers remain widespread, these insights serve as a critical reminder: everyday habits can have life-altering consequences.
Credits: iStock
Delhi finds itself in a little relief as the AQI of the city has dropped to 221 as per the CAQM. GRAP IV restrictions have also been lifted, however, pollution and smog continues to take over the city. The Meteorological Department has issued a yellow alert for the next few days, which could affect road and air traffic.
While GRAP IV is now removed, measures under GRAP I, II, and III will continue. As per the IMD forecast, this is what could happen for the next 5 days in Delhi
Nitin Gadkari, Union Minister of Road Transport and Highways also highlighted the alarming conditions of Delhi's smog and pollution. He said, "I stay for hardly two days in Delhi, and get an infection," as he spoke on how pollution impacts one's health conditions. However, he did speak on the severity of pollution and highlighted how the transport sector could play a huge role to bring relief to Delhi.
He highlighted that fuel combustion and transport emission leads to most of Delhi pollution.
In an interview with the news agency ANI, the minister also said that his ministry and Central Government are working on several projects and initiatives that will free Delhi from air pollution in the next five years.
Gadkari stated that the Ministry of Road Transport and Highways is undertaking projects worth Rs 1 lakh crore in Delhi to ease traffic congestion. He stated that all these efforts will not only help free Delhi of air pollution but also reduce the country's imports, increase job opportunities, and help farmers.
The minister highlighted that 40% of the air pollution in the National Capital region is due to the burning of fossil fuels. In this regard, the government introduced electric buses in the city and enabled automakers to introduce electric cars and two-wheelers in the country.
He further stated that alternate fuel vehicles, such as those that run on CNG, LPG, and flex fuels (E20), are also being introduced and that all these efforts combined will reduce the city's pollution levels.
Gadkari pointed out that nearly 200 lakh tonnes of rice straw or parali is burnt in Haryana and Punjab, a major cause of air pollution in the Delhi-NCR region. In this regard, the government is setting up 400 plants to convert the rice straw into CNG. At the moment, 60 plants are operational.
The minister also discussed a new project in Panipat in which rice straw is being used to create 1 lakh litres of Ethanol, 1.5 tonnes of bitumen, and 78,000 tonnes of jet fuel.
© 2024 Bennett, Coleman & Company Limited